雷火灸治疗泪液缺乏性干眼症疗效观察

目的:观察单纯雷火灸治疗泪液缺乏性干眼症的临床疗效.方法:将70例泪液缺乏性干眼症患者随机分成雷火灸组和人工泪液组.雷火灸组36例,对眼周穴位攒竹、鱼腰、瞳子髎、太阳、四白、睛明等给予雷火灸治疗,并配合眼周穴位及泪腺按摩.人工泪液组34例,局部点泪然滴眼液.观察2组治疗前后主要症状、泪液分泌试验、泪膜破裂时间及角膜荧光染色的变化.结果:2组患者眼部干涩感、异物感、视疲劳和整体症状较治疗前均有显著改善(P<0.01),并且在干燥感、异物感及整体症状的改善上,雷火灸组要优于人工泪液组(P<0.05);雷火灸组泪液分泌试验较治疗前具有显著改善(P<0.05),优于人工泪液组(P<0.05);2组泪膜破裂时间、角膜荧光素染色较治疗前均有显著改善(P<0.05),其中雷火灸组泪膜破裂时间改善较人工泪液组显著(P<0.05).结论:雷火灸治疗泪液缺乏性干眼症疗效好.

Observation on therapeutic effect of moxibustion with thunder-fire herbal moxa stick on xerophthal-mia of oligodacrya

OBJECTIVE: To observe clinical therapeutic effect of moxibustion with thunder-fire herbal moxa stick on xerophthalmia of oligodacrya. METHODS: Seventy cases were randomly divided into an observation group and a control group. The observation group (n=36) were treated with moxibustion with thunder-fire herbal moxa stick at Cuanzhu (BL 2), Yuyao (EX-HN 4), Tongziliao (GB 1), Taiyang (EX-HN 5), Sibai (ST 2), Jingming (BL 1), etc. and massage of acupoints and lacrimal gland around the eye. The control group (n=34) were treated with local dripping Leiran Diyanye. Changes of the main symptoms, tears secretion test, lacrimal membrane breaking time and corneal fluorescent staining before and after treatment were observed in the two groups. RESULTS: After treatment, sensation of dryness and foreign body sensation in the eye, asthenopia and gross symptoms significantly improved (P<0.01) in the two groups, and the observation group in the improvement of the sensation of dryness and foreign body sensation in the eye and the gross symptoms was better than the control group (P<0.05); tears secretion test significantly improved and was better in the observation group than that in the control group (P<0.05); lacrimal membrane breaking time and corneal fluorescent staining were improved in the two groups (P<0.05), and the improvement of lacrimal membrane breaking time in the observation group was more obvious than that in the control group (P<0.05). CONCLUSION: Moxibustion with thunder-fire herbal moxa stick has good therapeutic effect on xerophthalmia of oligodacrya.